Quick Answer
BioXcel Therapeutics, Inc. reported Total Assets of $44.92 million for fiscal year 2025.
BioXcel Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $44.92M | +17.2% |
| 2024 | $38.34M | -48.0% |
| 2023 | $73.70M | -64.2% |
| 2022 | $205.85M | -14.0% |
| 2021 | $239.44M | +8.9% |
| 2020 | $219.94M | +504.4% |
| 2019 | $36.39M | -16.4% |
| 2018 | $43.55M | +3113.9% |
| 2017 | $1.35M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $44.79M | -8.4% | +73.7% |
| June 30, 2025 | $25.79M | -60.6% | -33.1% |
| March 31, 2025 | $38.57M | -53.2% | +0.6% |
| December 31, 2024 | $38.34M | -48.0% | -21.6% |
| September 30, 2024 | $48.89M | -51.3% | -25.3% |
| June 30, 2024 | $65.44M | -53.3% | -20.5% |
| March 31, 2024 | $82.32M | -54.3% | +11.7% |
| December 31, 2023 | $73.70M | -64.2% | -26.6% |
- BioXcel Therapeutics, Inc. showed an increase of +17.2% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, BioXcel Therapeutics, Inc.’s total assets has grown by 3214.8% (from $1.35 million to $44.92 million).
- The most recent figure is from BioXcel Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: